Exco InTouch Appoints Chief Operating Officer
News Sep 14, 2016
Exco InTouch has announced that it has appointed Steve Powell as the company's Chief Operating Officer and President. In this newly created position Powell will be responsible for all aspects of Exco InTouch’s operational delivery including services and technology. “The recent growth in the eCOA (electronic Clinical Outcome Assessments) market, combined with the continued growth we have experienced here at Exco InTouch in both clinical and commercial markets, has led to the creation of this new position”, commented Tim Davis, CEO and Founder.
“I have personally known Steve for a long time and believe he will be an invaluable addition to our senior management team and board of directors. Steve possesses extensive industry experience and is very much a distinguished veteran of the sector. Indeed, he’s been involved in clinical technology, including eCOA, throughout his career as well as in two private equity transactions and a successful IPO. His skill set and track record of growing small through to large companies makes him the ideal person to head up this team”.
Powell will be based in the company’s North Carolina office, enabling him to support the organization’s expanding US customer base and developing its global expansion. He has 25 years’ experience in the healthcare sector, focused on operational and technology growth in the clinical research organization (CRO) and pharma/biotech markets and has especially strong knowledge of the management of patient data capture and analysis. His previous role was as Executive Vice President at a top 5 CRO, where he managed a large global team and contributed to its successful operational development and financial success.
Commenting on his appointment, Powell remarked: “I am delighted to be joining a company which has such great ambitions for the future, not just in clinical trials but in the wider commercial health industry as well. My personal connections with Tim and the team have allowed me to watch Exco InTouch grow since it was founded in 2004 and to understand how their technology plays such a crucial role in shaping the way patients, sites and sponsors engage in clinical trials.”
He continued: “To join at such a pivotal time for Exco InTouch and help drive the company’s potential in the mobile technology industry is very exciting. Exco has developed into an industry leader in its field, and has a long established track record for bringing innovative mobile and digital technology to the clinical and healthcare sectors. With the recent introduction of Gather™, the company is set to grow to dominate the market for data capture and patient engagement solutions for clinical research and commercial healthcare programs and I’m looking forward to ensuring its continued success.”
Chemists Design More Efficient Microreactor Using 3D PrintingNews
Researchers developed an electrochemical microreactor using additive manufacturing technology (commonly known as 3D printing). The newly developed microreactor was tested on synthesis of isoindolinones, which are found in many natural products, pharmaceuticals, and biologically active molecules.READ MORE
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
New Bioprocessing Technique Set to Revolutionize Cell CultureNews
A technique which revolutionises cell culture by allowing the continuous production and collection of cells, has been developed by scientists at Newcastle University. The Newcastle team have developed a coating that allows individual stromal cells to “peel away” from the surface on which they are grown.READ MORE